What do systematic reviews say?

Intervention not reported

It is very uncertain whether the intervention changes number of patients with at least 30% pain reduction (very low certainty).

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  RD 0.1 [0.01, 0.2]
  6 studies · 343 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes number of patients with a clinically important global improvement (very low certainty).

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  RD 0.14 [0.06, 0.23]
  6 studies · 330 participants
  Very low

Intervention not reported

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 192 participants
  Very low

Intervention not reported

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 193 participants
  Very low

Intervention not reported

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 244 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes discontinuation due to adverse events (very low certainty).

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  RD 0.04
  5 studies · 284 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes serious adverse events (very low certainty).

• Selective serotonin reuptake inhibitors for fibromyalgia syndrome 2015 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 168 participants
  Very low